Skip to content

Effects of propofol and ciprofol on percutaneous cerebral vascular stent implantation

Effects of propofol and ciprofol on percutaneous cerebral vascular stent implantation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089304
Enrollment
Unknown
Registered
2024-09-05
Start date
2024-09-10
Completion date
Unknown
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral vascular disease

Interventions

ciprofol:ciprofol

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective surgery; 2. Male or female; 3. Aged 18-65 years old; 3. ASA I - III level; 4 Body mass index (BMI) 18-30 kg/m2; 5. Clear consciousness, comprehension and normal speech function.

Exclusion criteria

Exclusion criteria: 1. Suspected difficult airway; 2. Patients with known allergy to the excipients of propofol or cyclopropofol; 3. Severe cardiovascular diseases: uncontrolled hypertension SBP> 180mmHg and/or DBP> 110mmHg, severe arrhythmia, heart failure, unstable angina, and myocardial infarction within the past 6 months; 4. Respiratory diseases: respiratory insufficiency, history of obstructive lung disease, history of bronchospasm requiring treatment within 3 months, acute respiratory infection within 1 week before the baseline period with obvious fever, wheezing or expectorative cough; 5. Patients with liver and kidney dysfunction; 6. The operation time is less than 1 hour; 7. Patients undergoing any surgery on other sites.

Design outcomes

Primary

MeasureTime frame
BP;wake time;

Countries

China

Contacts

Public Contactzhuzefei

The First Affiliated Hospital of Zhengzhou University

zhuzefeisimida@163.com+86 188 3806 6015

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026